global injection pen market is anticipated to expand at a compounded annual
growth rate (CAGR) of 6.0% during the forecast period of 2022-2030.
pens, also known as insulin pens, are specially designed advanced prefilled
syringes used for self-administration of drug delivery in several treatments
and chronic conditions. With the help of
these pens, hormone or drugs in small amounts are injected into the patient's
body for the treatment of targeted diseases. These pens are portable, more
accurate, simple, user-friendly, and convenient in delivery and effectively
replace traditional injections methods for addressing a variety of medical
factors driving the growth of this market include: the burgeoning prevalence of
diseases such as diabetes and arthritis among people across the globe; the
soaring demand for safer and advanced drug delivery devices; the
ever-increasing geriatric population; the growing technological advancements in
injection pens; the escalating number of regulatory approvals and presence of favorable
reimbursement scenario in matured economies; the rising usage of home health
care; the increasing government healthcare expenditure and availability of
favorable healthcare insurance policies etc.
as the usage of injection pens is rising among people suffering from insulin
related problems across the world, the manufacturers present in the injection
pen market are seen to putting major emphasis on enhancing the: design
parameters of the injection pens, the injection convenience, insulin-dose
setting dial use, ease of cartilage replacement and prominence of audio clicks.
This factor is anticipated to bode tremendously well for the growth of the
global injection market during the forecast period.
the invariable success achieved by injection pens in the management of various
chronic as well as acute diseases, has now directed the focus of the studies on
the application of these pens in major diseases that require periodic dose
injections, including cancer, multiple sclerosis, Hepatitis C, etc. This factor
is projected to create ample growth opportunities for the growth of the global
injection pen market during the forecast period.
factors such as the dearth of awareness concerning the usage of injection pens,
the high cost associated with injection pens, and the growing preference for
alternate drug delivery modes owing to fear of syringes are expected to hinder
the growth of the global injection pen market to comes extent during the
Disposable Injection Pens
Reusable Injection Pens
By End User:
Hospital & Clinics
Growth Hormone Therapy
Middle East and Africa
Based on type, the disposable injection pens segment captured the largest
share of the global injection pen market in 2021. The segment is predicted to
continue with its dominance in the market further during the forecast period of
2022-2030. The ease-of-use attribute of these pens and the presence of a
built-in cartridge system that eradicates the need for manually loading the
cartridge, making it more convenient for patients with reduced dexterity or
visual impairments, is the major factor attributable to the large share of this
Based on therapy, the diabetes segment acquired the largest share of the
global injection pen market in 2021. This trend is estimated to remain
unchanged over the forecast period of 2022-2030. The rapidly surging prevalence
of diabetes; and the rising awareness about insulin pens among diabetic
patients are the predominant factors driving the growth of this segment.
Based on end user, the home care segment is slated to witness the highest
growth in the market during the forecast period. Factors such as the increasing
base of the old-age population, the ease of drug administration, the escalating
rate of technological advancements, and favorable reimbursement scenarios across
various regions are primarily ascribed to the growth of this particular segment.
American region dominated the global injection pen market in 2021. The region
is anticipated to retain its dominance further in the market during the
forecast period due to the rising population base suffering from diabetes; the
increasing number of technological advancements, well-established market players,
and the surging awareness among people about injection pens in the region. The
U.S. and Canada are the major contributors to the growth of the market in the
region also held a prominent share in the global injection pen market in 2021.
The region is projected to witness robust growth in the market during the
forecast period. The growth of the market in the region can be attributed to
the soaring diabetes cases in the region, which is compelling the manufacturers
to develop effective and convenient ways to handle the disease.
Pacific region is poised to emerge as the fastest-growing regional market for
injection pen during the forecast period owing to rapid population growth; the
rising patient base; the surging cases of diabetes; the increasing entry of new
players offering new and advanced products in the region; the availability of
cost-effective injection pens and the escalating healthcare expenditure in the
region. India and China are the major contributors to the growth of the market
in the region.
Key Companies in
Injection Pen Market:
Roche Holding AG
Becton Dickinson and Company
Eli Lilly Company
F. Hoffman-La Roche
Owen Mumford Ltd